Jef Feeley and Sophia Pearson
Bloomberg.com
October 13, 2009

GlaxoSmithKline Plc must pay $2.5 million over claims that its Paxil antidepressant caused birth defects, a Pennsylvania jury concluded in the first of 600 such cases to come to trial.

Jurors in state court in Philadelphia deliberated about seven hours over two days before finding Glaxo failed to properly warn doctors and pregnant users of Paxil’s risk. The panel awarded $2.5 million in compensatory damages to the family of Lyam Kilker. The 3-year-old was born with heart defects his mother blamed on the drug.

“The first win is always huge, especially when you get a jury saying the drug caused the injury,” Sean Tracey, the family’s lawyer, said in an interview after the verdict.

It’s the first time a jury has considered claims that Glaxo, the U.K.’s largest drugmaker, knew Paxil caused birth defects and hid the risk to increase profits. The drug, approved for U.S. use in 1992, generated about $942 million in sales last year, or 2.1 percent of Glaxo’s total revenue.

Read entire article: http://www.bloomberg.com/apps/news?pid=20601103&sid=a3MSErCD3DfY

« Return to news items

News Feed

Related Posts

• Glaxo To Pay $1Billion To Settle Paxil Birth Defect Cases (0)
• GlaxoSmithKline Enters into Confidential Settlement with 200 Families Who Say Paxil Caused Birth Defects (0)
• Paxil Birth Defect Litigation – 600 Cases Pending (2)
• Glaxo Said to Have Paid $1 Billion in Paxil Suits Including About $390 Million for Suicides/Attempted Suicides Linked to Drug (1)
• Glaxo To Book $2.4 billion To Settle Legal Cases, Including Avandia, Paxil (0)

Tags: $2.5 million, birth defects, Glaxo, GlaxoSmithKline, paroxetine, Paxil, verdict

This entry was posted on Tuesday, October 13th, 2009 at 3:21 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed.

You can leave a response, or trackback from your own site.